Biological E. Limited

Biological E. Limited (BE) is an Indian biopharmaceutical company committed to improving global health through the development and supply of quality vaccines and pharmaceutical products.

Founded in 1953 by Dr. D.V.K. Raju, BE began its journey manufacturing liver extracts and anti-coagulants during India's Swadeshi Movement, a time when the nation sought access to critical healthcare products. In 1962, the company expanded into vaccine production, becoming the first private Indian company to do so, with the large-scale manufacture of DPT vaccines. Today, BE operates three strategic business units: Branded Formulations, Speciality Generic Injectables, and Vaccines & Biologics. The company supplies vaccines to over 130 countries and offers therapeutic products in India, the USA, and Europe. BE's portfolio includes nine WHO-prequalified vaccines and ten USFDA-approved generic injectables.

Key Products and Services:

• Vaccines & Biologics: BE offers a range of vaccines, including those for diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, measles, rubella, Japanese encephalitis, and typhoid. The company has also developed a 14-valent pneumococcal conjugate vaccine, PNEUBEVAX 14™, which has demonstrated safety and immunogenicity in infants.

• Speciality Generic Injectables: Leveraging its expertise in sterile manufacturing, BE focuses on developing and commercialising injectable products, primarily non-biological complex drugs, as well as routine injectables.

• Branded Formulations: BE offers a diverse portfolio of branded pharmaceutical products across various therapeutic areas, catering to the healthcare needs of patients in India and other markets.

Under the leadership of Managing Director Mahima Datla, BE continues to evolve, aiming to become the largest Indian vaccines company by 2025 and to be among the top Indian companies in complex generics and speciality pharmaceuticals. The company's commitment to quality, innovation, and integrity drives its mission to improve health and survival by providing equitable access to essential healthcare solutions.